NHS-PEG4-GGFG-DXD
PG-20161-69477
Product information
- Catalog No.
- PG-20161-69477
- Product Name
- NHS-PEG4-GGFG-DXD
- CAS No.
- Not specified
- Molecular Formula
- C58H68FN9O19
- Molecular Weight
- 1214.2
- Purity
- 95%
- Storage
- -20°C
- Shipping
- Ambient Temperature
- Documents
Missing values are marked “Not specified”. Request the technical information you need with your inquiry. For research use only.
Packaging & pricing
| Catalog No. | Packaging | Price (USD) | Stock | Inquiry action |
|---|---|---|---|---|
| PG-20161-69477 | 1 MG | Inquiry | In stock | |
| PG-20161-69477 | 5 MG | Inquiry | In stock | |
| PG-20161-69477 | 10 MG | Inquiry | In stock | |
| PG-20161-69477 | 25 MG | Inquiry | In stock |
Final pricing, package availability and delivery are confirmed with your quotation.
General Information
- Product Name
- NHS-PEG4-GGFG-DXD
- CAS No.
- Not specified
- Synonyms
- Not specified
- Molecular Formula
- C58H68FN9O19
- Molecular Weight
- 1214.2
- Appearance
- Not specified
- Solubility
- DMSO, DMF
- Description
NHS-PEG4-GGFG-DXD is a tetrapeptide linker-payload for antibody-drug conjugate (ADC) preparation. It combines an amine-reactive NHS group with a PEG4 segment, an intracellularly protease-cleavable GGFG sequence, and DXD. The DXD payload is an Exatecan derivative that inhibits DNA topoisomerase I, while the PEG4 segment supports aqueous solubility. The product has a molecular formula of C58H68FN9O19 and a listed purity of 95%; DMSO and DMF are specified as solvents.